Finally, the fact that 5a can recognize the LAP-TGFβ complex-binding site of both αvβ6 and αvβ8 integrins opens the way to another potential application of this peptide in cancer therapy, i.e., targeting TGFβ activation in the tumor microenvironment. This evidence concerns the gene TGFB1 and neoplasm.